Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes

BackgroundPrion infection results in progressive neurodegeneration of the central nervous system invariably resulting in death. The pathological effects of prion diseases in the brain are morphologically well defined, such as gliosis, vacuolation, and the accumulation of disease-specific protease-resistant prion protein (PrPSc). However, the underlying molecular events that lead to the death of neurons are poorly characterised.ResultsIn this study cDNA microarrays were used to profile gene expression changes in the brains of two different strains of mice infected with three strains of mouse-adapted scrapie. Extensive data was collected and analyzed, from which we identified a core group of 349 prion-related genes (PRGs) that consistently showed altered expression in mouse models. Gene ontology analysis assigned many of the up-regulated genes to functional groups associated with one of the primary neuropathological features of prion diseases, astrocytosis and gliosis; protein synthesis, inflammation, cell proliferation and lipid metabolism. Using a computational tool, Ingenuity Pathway Analysis (IPA), we were able to build networks of interacting genes from the PRG list. The regulatory cytokine TGFB1, involved in modulating the inflammatory response, was identified as the outstanding interaction partner for many of the PRGs. The majority of genes expressed in neurons were down-regulated; a number of these were involved in regulatory pathways including synapse function, calcium signalling, long-term potentiation and ERK/MAPK signalling. Two down-regulated genes coding for the transcription regulators, EGR1 and CREB1, were also identified as central to interacting networks of genes; these factors are often used as markers of neuronal activity and their deregulation could be key to loss of neuronal function.ConclusionThese data provides a comprehensive list of genes that are consistently differentially expressed in multiple scrapie infected mouse models. Building networks of interactions between these genes provides a means to understand the complex interplay in the brain during neurodegeneration. Resolving the key regulatory and signaling events that underlie prion pathogenesis will provide targets for the design of novel therapies and the elucidation of biomarkers.

[1]  Wolfgang Schmid,et al.  Disruption of CREB function in brain leads to neurodegeneration , 2002, Nature Genetics.

[2]  Nan Zhang,et al.  Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. , 2002, Archives of biochemistry and biophysics.

[3]  A. Johnston,et al.  Synaptic Plasticity in the CA1 Area of the Hippocampus of Scrapie-Infected Mice , 1998, Neurobiology of Disease.

[4]  E. Masliah,et al.  Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain , 2003, Neuron.

[5]  B. Chesebro,et al.  Scrapie‐specific neuronal lesions are independent of neuronal PrP expression , 2004, Annals of neurology.

[6]  Jeffrey T. Leek,et al.  Erratum: EDGE: Extraction and analysis of differential gene expression (Bioinformatics (2006) vol. 22 (4) (507-508)) , 2006 .

[7]  E. Mackenzie,et al.  A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  Miia Kivipelto,et al.  Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment? , 2006, Neuroscience Letters.

[9]  Martin Dugas,et al.  Identification of Differentially Expressed Genes in Scrapie-Infected Mouse Brains by Using Global Gene Expression Technology , 2004, Journal of Virology.

[10]  Veeranna,et al.  Phosphorylation of MEK1 by cdk5/p35 Down-regulates the Mitogen-activated Protein Kinase Pathway* , 2002, The Journal of Biological Chemistry.

[11]  I. Weiler,et al.  Correspondence between sites of NGFI-A induction and sites of morphological plasticity following exposure to environmental complexity. , 1995, Brain research. Molecular brain research.

[12]  T. Wyss-Coray,et al.  Increased T Cell Recruitment to the CNS after Amyloid β1–42 Immunization in Alzheimer's Mice Overproducing Transforming Growth Factor-β1 , 2006, The Journal of Neuroscience.

[13]  V. Perry,et al.  Transforming growth factor β1, the dominant cytokine in murine prion disease: influence on inflammatory cytokine synthesis and alteration of vascular extracellular matrix , 2002, Neuropathology and applied neurobiology.

[14]  E. Mackenzie,et al.  Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. , 2003, The Journal of biological chemistry.

[15]  J. Collinge,et al.  Hippocampal slices from prion protein null mice: disrupted Ca2+-activated K+ currents , 1996, Neuroscience Letters.

[16]  C. Cunningham,et al.  Atypical inflammation in the central nervous system in prion disease , 2002, Current opinion in neurology.

[17]  B. Dolenko,et al.  Molecular classification of scrapie strains in mice using gene expression profiling. , 2004, Biochemical and biophysical research communications.

[18]  I. Izquierdo,et al.  Phosphorylated cAMP Response Element-Binding Protein as a Molecular Marker of Memory Processing in Rat Hippocampus: Effect of Novelty , 2000, The Journal of Neuroscience.

[19]  E. Mackenzie,et al.  A Transforming Growth Factor-β Antagonist Unmasks the Neuroprotective Role of This Endogenous Cytokine in Excitotoxic and Ischemic Brain Injury , 1999 .

[20]  Robert B. Moulden,et al.  Molecular analysis of bovine spongiform encephalopathy infection by cDNA arrays. , 2007, The Journal of general virology.

[21]  V. Perry,et al.  TGFβ1 regulates the inflammatory response during chronic neurodegeneration , 2006, Neurobiology of Disease.

[22]  V. Haroutunian,et al.  Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer’s Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer’s Disease? , 2007, Neurochemical Research.

[23]  Jeffrey T Leek,et al.  The optimal discovery procedure for large-scale significance testing, with applications to comparative microarray experiments. , 2007, Biostatistics.

[24]  E. Nishida,et al.  ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1 , 2001, Nature Cell Biology.

[25]  Michal Linial,et al.  Novel Unsupervised Feature Filtering of Biological Data , 2006, ISMB.

[26]  L. Manuelidis,et al.  Microglial Activation Varies in Different Models of Creutzfeldt-Jakob Disease , 1999, Journal of Virology.

[27]  M. Buckwalter,et al.  Molecular and Functional Dissection of TGF‐β1‐Induced Cerebrovascular Abnormalities in Transgenic Mice , 2002, Annals of the New York Academy of Sciences.

[28]  Julia Schultz,et al.  Gene expression profiling of scrapie-infected brain tissue. , 2004, Biochemical and biophysical research communications.

[29]  V. Bader,et al.  Sgk1, a cell survival response in neurodegenerative diseases , 2005, Molecular and Cellular Neuroscience.

[30]  Andrew J. Cole,et al.  Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation , 1989, Nature.

[31]  L. Haynes,et al.  The pleiotropin/midkine family of cytokines: role in glial-neuronal signalling. , 2001, Progress in brain research.

[32]  Jeffrey T. Leek,et al.  Gene expression EDGE : extraction and analysis of differential gene expression , 2006 .

[33]  Russell Schwartz,et al.  A comparative genomics approach to identifying the plasticity transcriptome , 2007, BMC Neuroscience.

[34]  H. Kretzschmar,et al.  Loss of the cellular prion protein affects the Ca2+ homeostasis in hippocampal CA1 neurons , 2006, Journal of neurochemistry.

[35]  Pamela J Skinner,et al.  Gene expression alterations in brains of mice infected with three strains of scrapie , 2006, BMC Genomics.

[36]  D. Marchionini,et al.  Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease , 2007, Brain Research.

[37]  Hyun-pil Lee,et al.  Activation of mitogen‐activated protein kinases in hamster brains infected with 263K scrapie agent , 2005, Journal of neurochemistry.

[38]  W. Wong,et al.  Molecular diversity of astrocytes with implications for neurological disorders. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Kevin A. Robertson,et al.  Gene expression profiling of the preclinical scrapie-infected hippocampus. , 2005, Biochemical and biophysical research communications.

[40]  Hyun-pil Lee,et al.  Activation of mitogen-activated protein kinases in hamster brains infected with 263 K scrapie agent , 2005 .

[41]  P A Insel,et al.  Protein kinase C isozymes and the regulation of diverse cell responses. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[42]  Mark T. Harnett,et al.  Transcriptional Signatures of Cellular Plasticity in Mice Lacking the α1 Subunit of GABAA Receptors , 2006, The Journal of Neuroscience.

[43]  S. Prusiner,et al.  Scrapie infection of transgenic mice leads to network and intrinsic dysfunction of cortical and hippocampal neurones , 1994, Neurobiology of Disease.

[44]  J. Koistinaho,et al.  Induction of Protein Kinase Cδ Subspecies in Neurons and Microglia after Transient Global Brain Ischemia , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  E. Mackenzie,et al.  Transforming Growth Factor-β1 Potentiates Amyloid-β Generation in Astrocytes and in Transgenic Mice* , 2003, The Journal of Biological Chemistry.

[46]  M. Deckert,et al.  Pathological Prion Protein Exposure Switches on Neuronal Mitogen-activated Protein Kinase Pathway Resulting in Microglia Recruitment* , 2005, Journal of Biological Chemistry.

[47]  U. Mansmann,et al.  Transcriptome analysis reveals altered cholesterol metabolism during the neurodegeneration in mouse scrapie model , 2007, Journal of neurochemistry.

[48]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[49]  Richard Baumgartner,et al.  Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection. , 2004, The Journal of general virology.

[50]  C. Carter,et al.  Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis , 2007, Neurochemistry International.

[51]  H. True,et al.  New Insights into Prion Structure and Toxicity , 2006, Neuron.

[52]  Sebastian Brandner,et al.  Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis , 2003, Science.

[53]  C. Holmgren,et al.  Intrinsic Physiological and Morphological Properties of Principal Cells of the Hippocampus and Neocortex in Hamsters Infected with Scrapie , 1999, Neurobiology of Disease.

[54]  A. Riccio,et al.  Apoptosis, Axonal Growth Defects, and Degeneration of Peripheral Neurons in Mice Lacking CREB , 2002, Neuron.

[55]  T. Bliss,et al.  A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories , 2001, Nature Neuroscience.

[56]  A. Takeda,et al.  Induction of heparin-binding growth-associated molecule expression in reactive astrocytes following hippocampal neuronal injury , 1995, Neuroscience.